The oncogenic E3 ligase TRIP12 suppresses epithelial-mesenchymal transition (EMT) and metastasis-related processes through ZEB1/2
K. K. Lee, D. Rajagopalan, S. S. Bhatia, W. J. Chng, S. Jha
This study shows TRIP12 suppresses EMT and metastasis by inhibiting ZEB1/2 in breast cancer, based on patient data and cell experiments.
bioRxiv · Nov 4, 2020Cancer Biology